Unless researchers solve the looming data storage problem, biomedical science could stagnate
THE FUTURE OF GLOBAL HEALTHCARE Bio Convergence It’s a revolution, a mass convergence of multiple fields Bio convergence We live in a post-genomic era, where data, molecular engineering, and new frameworks redefine possibilities. Researchers, engineers, and biotech firms are moving beyond the “nature-inspired” paradigm. The lines between biology, engineering, nanotech, and IT are becoming increasingly […]
Unique genetics that are sure to leave people in awe
Explore the journey behind The Genomic Kitchen Guide to Understanding the Food Gene Connection. Get a peek inside the contents and learn how to get the best Return On Ingestion (R.O.I.).
An interview with genome and synthetic life scientist J. Craig Venter.
These flowcharts were drawn for Biochem 2280 at the University of Western Ontario but should be useful for any student taking introductory biology! Topics covered include transcription, translation…
Metagenomi is a California-based startup that employs the power of metagenomics and couples it with machine learning to develop novel genome editing systems. The organization uses metagenomics to find 4 billion years' worth of microbial evolution. The company has the potential to improve upon the already existing gene-editing steps and magnify them for a better reach and outcome. Recently, Metagenomi raised a whopping $75 million in the Series A funding round, which takes the total capital raised to around $101 million. The funds collected will be utilized to expand the team and develop the company's therapeutic pipeline. This gene-editing startup
A bundle of notes & mindmaps made using the OCR a level biology specification, my class notes, the OCR textbook & YouTube videos. Includes 40 pages of summarised content covering: - Cellular Control - Patterns of Inheritance - Manipulating Genomes - Cloning + Biotech - Ecosystems - Carbon + Nitrogen Cycle
[IMG] Having experienced unprecedented growth since the turn of the millennium, the dramatic expansion of resources and techniques in fungal genomics...
A program has been used to predict the structures of nearly every protein in the human body.
Из всех известных мне технических и естественных наук, пожалуй, именно о биоинформатике представление у людей самое плохое. Оно либо в той или иной степени невер...
Next Generation Sequencing (NGS) is used to sequence both DNA and RNA. Billions of DNA strands get sequenced simultaneously using NGS. Whereas with Sanger Sequencing, only one strand gets sequenced at a time. Learn about the steps involved in NGS, from nucleic acid extraction to DNA alignment and analysis.
GEN celebrates the 10th anniversary of the completion of the public and private efforts aimed at sequencing the human genome.
Two companies are teaming up to make a super-personalized health app.
Continuing from my last post, the Cyprus Experiment: …However, if you start playing with genes in order to create the perfect society…that becomes another thing alltogether. Imagine this: genes editing can lead to a situation in which you can choose from a catalog the physical characteristics and personality type of your offspring. “Yes, I would … Continue reading "CRISPR-Cas9 Genome Editing: the Rise of the Super Elite, China and Personalized Bio-weapons"
Advances in technology have enabled researchers to sequence the large regions of repetitive DNA that eluded the Human Genome Project.
RNA Interference – Gene Silencing by Double-Stranded RNA Andrew Z. Fire & Craig C. Mello Nobel Prize Award in Medicine 2006 Introduction This year's Nobel Laureates have discovered a fundamental mechanism for controlling the flow of genetic information. Our genome operates by sending instructions for the manufacture of proteins…
Collecting genome data is reliable, fast and cheap. Yet, interpreting that data is unreliable, slow, and expensive -- when it's even possible. Today, genome interpretation is a burgeoning science, but it's not yet a technology. A stricken patient has their genes sequenced and their mutations identified. But then, it can take a highly trained, and highly paid, expert many hours to make a judgment call on a single unfamiliar mutation.
Unique genetics that are sure to leave people in awe
Overcoming challenges and implementing solutions for the reproducibility problem in biological research to get accurate and transparent scientific findings.
Plasmids are extra-chromosomal genetic elements ubiquitous in bacteria, and commonly transmissible between host cells. Their genomes include variable reperto...
BI PRIME: One biotech veteran sees the microbiome as "the next paradigm shift in science and medicine."
[IMG] This volume provides a collection of protocols for the study of DNA-DNA contact maps, replication profiles, transcription rates, RNA secondary...
As the world of DNA sequencing becomes more efficient and less expensive, a number of companies are sprouting up within the space. The latest, Phosphorus,
Classification of viruses on the basis of genome. Viral nomenclature has used a variety of virion features. Effort to classify viruses
Learn about other technologies that can solve big problems: Self-Driving Cars Carbon Capture Nanopore Desalination
Some of the weakness in biotech is a product of the approaching presidential election. We’re heading into an election year, and for many people in a highly regulated industry, this means uncertainty. Uncertainty hurts high-beta names. Investors could manage the risk posed by potential changes to the U.S. regulatory environment around drug pricing by taking a close look at their portfolios. Just look at where a company’s positioned in Europe and the rest of the world versus the U.S. If 90% of its sales are U.S. based due to higher prices, it’s more exposed. The public markets are vastly undervaluing the three companies that control the foundational patents for the most promising gene-editing technique, called CRISPR-CAS9: Intellia Therapeutics (NTLA), Crispr Therapeutics (CRSP), and Editas Medicine (EDIT). These companies, which are at the cusp of curing disease, are valued at such low valuations in the marketplace. Just $5 billion among the three of them. Intellia and Crispr Therapeutics have stronger patent positions than Editas.
A set of techniques adopted for gene cloning for a particular purpose is said to be a gene cloning strategy. There are several gene clonin...
Human "knockouts" could pave the way to new drug targets.
With the rise of spit-in-a-cup genetic testing, there's a trend of white nationalists using these services to prove their racial identity.
